September 25, 2024
Trending Now
1
FDA Approves IND for Liquid Botulinum Toxin Formulation
2
FDA Approves New Eczema Drug
3
Cyberbullying in Teen Girls Linked to Body Dissatisfaction and Eating Disorders
4
Melanoma Incidence Varies by Sex, Age, and Body Site
5
Veterans' Skin Cancer Risk: A Growing Concern?
6
Jeffrey S. Weber, MD, PhD, Melanoma and Immunotherapy Pioneer, Dies
Conference Coverage
2024 ASCO Annual Meeting
SSO 2021 International Conference on Surgical Cancer Care
AACR Annual Meeting 2023
Clinical Guidelines
View MoreJune 01, 2023
Check the Lids for Demodex Blepharitis
January 01, 2024
Streamlining Layered Composite Veneer Procedures
February 01, 2023
Pricing and Packaging Cataract Surgery
May 01, 2023
INNOVATION
Commentary & Perspectives
View MoreFDA & Government News
View MoreSeptember 25, 2024
FDA Approves IND for Liquid Botulinum Toxin Formulation
September 24, 2024
Pediatric Wards: Idaho Bursting, Alaska Empty
September 16, 2024
FDA Approves New Eczema Drug
September 13, 2024
FDA Greenlights New Cancer Injection
Business Management
View MoreSeptember 27, 2024
U.S. Nonprofit Hospitals Gained $37.4B in 2021 Tax Benefits
September 23, 2024
Physicians Urged to Scrutinize Employers Beyond Salary
August 30, 2024